Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-06-24

FDA Approved: PRUCALOPRIDE — Original Application (Sandoz Inc.)

View source ↗

Summary

FDA approved the original application for a generic version of prucalopride (PRUCALOPRIDE) by Sandoz Inc., for the treatment of chronic idiopathic constipation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PRUCALOPRIDE (Prucalopride)

Snippet

ORIG AP for PRUCALOPRIDE (PRUCALOPRIDE)